Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Design Pharmaceuticals applies robust ultra-high throughput bioscience technologies in a novel approach to dramatically accelerate GPCR drug discovery and outpace current industry capabilities. Their…

Design Pharmaceuticals applies robust ultra-high throughput bioscience technologies in a novel approach to dramatically accelerate GPCR drug discovery and outpace current industry capabilities. Their…
Focus: GPCR drug discovery using ultra-high-throughput multiplexed bioscience platform
Headquarters: Cambridge, United States
Stage / Funding: Seed — reported $5.0M (Feb 2022)
Company size (reported): 2–10 employees (reported); 3 employees (site snapshot)
GPCR-targeted drug discovery; accelerating identification of therapeutics where current options are inadequate.
2019
Biotechnology / Pharmaceutical
5000000.00
Reported by Dealroom as a Feb 2022 seed round of $5.0M; other sources list last funding date 2022-04-12.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
83,000+
Open Roles
4,500+
New This Week